WGU D027 ADVANCED PATHOPHARMACOLOGICAL
FOUNDATIONS TESTED QUESTIONS (LATEST )
AND VERIFIED RATIONALIZED ANSWERS, 100%
GUARANTEE PASS Q&A | INSTANT DOWNLOAD PDF
Core Domains
Cellular Adaptation, Injury, and Cell Death
Inflammation, Immunity, and Hypersensitivity
Genetics and Genomics in Disease
Pharmacokinetics and Pharmacodynamics
Cardiovascular Pathophysiology and Pharmacology
Respiratory, Renal, and Endocrine Disorders
Neurologic, Psychiatric, and Hematologic Pharmacology
Infectious Disease and Antimicrobial Therapy
Gastrointestinal, Musculoskeletal, and Reproductive Systems
Oncology and Multisystem Pathopharmacology
Introduction
The WGU D027 Advanced Pathopharmacological
Foundations assessment evaluates the advanced practice
nurse's ability to integrate pathophysiology, pharmacology,
and clinical decision-making across the lifespan. It assesses
knowledge of cellular injury, genetic influences, immune
responses, and drug pharmacokinetics and
pharmacodynamics, alongside the management of major
,body systems. The examination uses multiple-choice and
scenario-based questions to measure real-world application,
critical thinking, and safe prescribing practices. Candidates
must demonstrate competency in applying foundational
science to complex patient presentations, ensuring therapeutic
efficacy, and minimizing adverse drug events in diverse
clinical settings.
SECTION ONE: QUESTIONS 1–150
1. Which pharmacokinetic process is most significantly
affected by decreased hepatic function?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
🟢 C. Metabolism
🔴 RATIONALE: The liver is the primary site of drug
metabolism. Impaired hepatic function reduces the
metabolism of many drugs, prolonging half-life and
increasing the risk of toxicity.
2. A patient with renal failure requires dosage adjustments
for which type of medication?
A. Drugs excreted unchanged by the kidneys
,B. Drugs metabolized by the liver
C. Topical corticosteroids
D. Sublingual nitroglycerin
🟢 A. Drugs excreted unchanged by the kidneys
🔴 RATIONALE: Drugs primarily cleared unchanged through
the kidneys accumulate when renal function declines,
necessitating dosage reduction to prevent toxicity.
3. Which receptor type is primarily targeted by beta-
blockers?
A. Alpha-1 adrenergic
B. Beta-adrenergic
C. Muscarinic
D. Dopaminergic
🟢 B. Beta-adrenergic
🔴 RATIONALE: Beta-blockers block beta-adrenergic
receptors in the heart, reducing heart rate, myocardial
contractility, and blood pressure.
4. A patient is diagnosed with a condition where a single
gene mutation causes an abnormal hemoglobin structure,
leading to sickle-shaped red blood cells. This type of
inheritance is best described as:
A. Autosomal dominant
, B. Autosomal recessive
C. X-linked recessive
D. Mitochondrial inheritance
🟢 B. Autosomal recessive
🔴 RATIONALE: Sickle cell disease is caused by an
autosomal recessive mutation in the beta-globin gene. The
patient must inherit two copies of the mutated gene to
express the disease.
5. Which genetic condition is characterized by a
trinucleotide repeat expansion (CAG) in the HTT gene,
leading to progressive neurodegeneration?
A. Fragile X syndrome
B. Huntington's disease
C. Duchenne muscular dystrophy
D. Tay-Sachs disease
🟢 B. Huntington's disease
🔴 RATIONALE: Huntington's disease is an autosomal
dominant disorder caused by a CAG trinucleotide repeat
expansion in the HTT gene, characterized by chorea,
cognitive decline, and psychiatric symptoms.
6. Which cellular adaptation is characterized by a decrease
in cell size and function?
FOUNDATIONS TESTED QUESTIONS (LATEST )
AND VERIFIED RATIONALIZED ANSWERS, 100%
GUARANTEE PASS Q&A | INSTANT DOWNLOAD PDF
Core Domains
Cellular Adaptation, Injury, and Cell Death
Inflammation, Immunity, and Hypersensitivity
Genetics and Genomics in Disease
Pharmacokinetics and Pharmacodynamics
Cardiovascular Pathophysiology and Pharmacology
Respiratory, Renal, and Endocrine Disorders
Neurologic, Psychiatric, and Hematologic Pharmacology
Infectious Disease and Antimicrobial Therapy
Gastrointestinal, Musculoskeletal, and Reproductive Systems
Oncology and Multisystem Pathopharmacology
Introduction
The WGU D027 Advanced Pathopharmacological
Foundations assessment evaluates the advanced practice
nurse's ability to integrate pathophysiology, pharmacology,
and clinical decision-making across the lifespan. It assesses
knowledge of cellular injury, genetic influences, immune
responses, and drug pharmacokinetics and
pharmacodynamics, alongside the management of major
,body systems. The examination uses multiple-choice and
scenario-based questions to measure real-world application,
critical thinking, and safe prescribing practices. Candidates
must demonstrate competency in applying foundational
science to complex patient presentations, ensuring therapeutic
efficacy, and minimizing adverse drug events in diverse
clinical settings.
SECTION ONE: QUESTIONS 1–150
1. Which pharmacokinetic process is most significantly
affected by decreased hepatic function?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
🟢 C. Metabolism
🔴 RATIONALE: The liver is the primary site of drug
metabolism. Impaired hepatic function reduces the
metabolism of many drugs, prolonging half-life and
increasing the risk of toxicity.
2. A patient with renal failure requires dosage adjustments
for which type of medication?
A. Drugs excreted unchanged by the kidneys
,B. Drugs metabolized by the liver
C. Topical corticosteroids
D. Sublingual nitroglycerin
🟢 A. Drugs excreted unchanged by the kidneys
🔴 RATIONALE: Drugs primarily cleared unchanged through
the kidneys accumulate when renal function declines,
necessitating dosage reduction to prevent toxicity.
3. Which receptor type is primarily targeted by beta-
blockers?
A. Alpha-1 adrenergic
B. Beta-adrenergic
C. Muscarinic
D. Dopaminergic
🟢 B. Beta-adrenergic
🔴 RATIONALE: Beta-blockers block beta-adrenergic
receptors in the heart, reducing heart rate, myocardial
contractility, and blood pressure.
4. A patient is diagnosed with a condition where a single
gene mutation causes an abnormal hemoglobin structure,
leading to sickle-shaped red blood cells. This type of
inheritance is best described as:
A. Autosomal dominant
, B. Autosomal recessive
C. X-linked recessive
D. Mitochondrial inheritance
🟢 B. Autosomal recessive
🔴 RATIONALE: Sickle cell disease is caused by an
autosomal recessive mutation in the beta-globin gene. The
patient must inherit two copies of the mutated gene to
express the disease.
5. Which genetic condition is characterized by a
trinucleotide repeat expansion (CAG) in the HTT gene,
leading to progressive neurodegeneration?
A. Fragile X syndrome
B. Huntington's disease
C. Duchenne muscular dystrophy
D. Tay-Sachs disease
🟢 B. Huntington's disease
🔴 RATIONALE: Huntington's disease is an autosomal
dominant disorder caused by a CAG trinucleotide repeat
expansion in the HTT gene, characterized by chorea,
cognitive decline, and psychiatric symptoms.
6. Which cellular adaptation is characterized by a decrease
in cell size and function?
